APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Human Immunoglobulin for Intravenous Injection

Compare research editions
View pricing & licenses

Selected research

Industry Research

Human Immunoglobulin for Intravenous Injection Industry Research Report 2026

Report ID 173999880531 December 2025127 pages

Choose your research edition.

Industry ResearchHuman Immunoglobulin for Intravenous Injection Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Immunoglobulin for Intravenous Injection Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Human Immunoglobulin for Intravenous Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Immunoglobulin for Intravenous Injection Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Immunoglobulin for Intravenous Injection Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Human Immunoglobulin for Intravenous Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Human Immunoglobulin for Intravenous Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Human Immunoglobulin for Intravenous Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Human Immunoglobulin for Intravenous Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Human Immunoglobulin for Intravenous Injection include Zhenghua Shenghua, Zhongyuan Ruide, Weiguang Biological, Tiantan Biological, Taibang Biological, Yuanda shuyang, Shanghai Laishi, Kangbao Biological and Nanyue Biological, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Human Immunoglobulin for Intravenous Injection market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Human Immunoglobulin for Intravenous Injection Market by Company

Zhenghua Shenghua

Zhongyuan Ruide

Weiguang Biological

Tiantan Biological

Taibang Biological

Yuanda shuyang

Shanghai Laishi

Kangbao Biological

Nanyue Biological

Lvshizi

Hualan Biological

Paisi feike

Boya Biological

Human Immunoglobulin for Intravenous Injection Segment by Type

Children

Adult

Human Immunoglobulin for Intravenous Injection Segment by Application

Treatment

Diagnosis

Disease Prevention

Other

Human Immunoglobulin for Intravenous Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Immunoglobulin for Intravenous Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Immunoglobulin for Intravenous Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Immunoglobulin for Intravenous Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Human Immunoglobulin for Intravenous Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Human Immunoglobulin for Intravenous Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Human Immunoglobulin for Intravenous Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Human Immunoglobulin for Intravenous Injection Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Human Immunoglobulin for Intravenous Injection Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Manufacturers (2021-2026) Table 8. Global Human Immunoglobulin for Intravenous Injection Revenue of Manufacturers (2021-2026) Table 9. Global Human Immunoglobulin for Intravenous Injection Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Human Immunoglobulin for Intravenous Injection Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Human Immunoglobulin for Intravenous Injection Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Human Immunoglobulin for Intravenous Injection, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Human Immunoglobulin for Intravenous Injection, Product Type & Application Table 14. Global Human Immunoglobulin for Intravenous Injection Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Human Immunoglobulin for Intravenous Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Zhenghua Shenghua Company Information Table 19. Zhenghua Shenghua Business Overview Table 20. Zhenghua Shenghua Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Zhenghua Shenghua Human Immunoglobulin for Intravenous Injection Product Portfolio Table 22. Zhenghua Shenghua Recent Developments Table 23. Zhongyuan Ruide Company Information Table 24. Zhongyuan Ruide Business Overview Table 25. Zhongyuan Ruide Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Zhongyuan Ruide Human Immunoglobulin for Intravenous Injection Product Portfolio Table 27. Zhongyuan Ruide Recent Developments Table 28. Weiguang Biological Company Information Table 29. Weiguang Biological Business Overview Table 30. Weiguang Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Weiguang Biological Human Immunoglobulin for Intravenous Injection Product Portfolio Table 32. Weiguang Biological Recent Developments Table 33. Tiantan Biological Company Information Table 34. Tiantan Biological Business Overview Table 35. Tiantan Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Tiantan Biological Human Immunoglobulin for Intravenous Injection Product Portfolio Table 37. Tiantan Biological Recent Developments Table 38. Taibang Biological Company Information Table 39. Taibang Biological Business Overview Table 40. Taibang Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Taibang Biological Human Immunoglobulin for Intravenous Injection Product Portfolio Table 42. Taibang Biological Recent Developments Table 43. Yuanda shuyang Company Information Table 44. Yuanda shuyang Business Overview Table 45. Yuanda shuyang Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Yuanda shuyang Human Immunoglobulin for Intravenous Injection Product Portfolio Table 47. Yuanda shuyang Recent Developments Table 48. Shanghai Laishi Company Information Table 49. Shanghai Laishi Business Overview Table 50. Shanghai Laishi Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Shanghai Laishi Human Immunoglobulin for Intravenous Injection Product Portfolio Table 52. Shanghai Laishi Recent Developments Table 53. Kangbao Biological Company Information Table 54. Kangbao Biological Business Overview Table 55. Kangbao Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Kangbao Biological Human Immunoglobulin for Intravenous Injection Product Portfolio Table 57. Kangbao Biological Recent Developments Table 58. Nanyue Biological Company Information Table 59. Nanyue Biological Business Overview Table 60. Nanyue Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Nanyue Biological Human Immunoglobulin for Intravenous Injection Product Portfolio Table 62. Nanyue Biological Recent Developments Table 63. Lvshizi Company Information Table 64. Lvshizi Business Overview Table 65. Lvshizi Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Lvshizi Human Immunoglobulin for Intravenous Injection Product Portfolio Table 67. Lvshizi Recent Developments Table 68. Hualan Biological Company Information Table 69. Hualan Biological Business Overview Table 70. Hualan Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Hualan Biological Human Immunoglobulin for Intravenous Injection Product Portfolio Table 72. Hualan Biological Recent Developments Table 73. Paisi feike Company Information Table 74. Paisi feike Business Overview Table 75. Paisi feike Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Paisi feike Human Immunoglobulin for Intravenous Injection Product Portfolio Table 77. Paisi feike Recent Developments Table 78. Boya Biological Company Information Table 79. Boya Biological Business Overview Table 80. Boya Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Boya Biological Human Immunoglobulin for Intravenous Injection Product Portfolio Table 82. Boya Biological Recent Developments Table 83. Global Human Immunoglobulin for Intravenous Injection Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 84. Global Human Immunoglobulin for Intravenous Injection Sales by Region (2021-2026) & (K Units) Table 85. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Region (2021-2026) Table 86. Global Human Immunoglobulin for Intravenous Injection Sales by Region (2027-2032) & (K Units) Table 87. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Region (2027-2032) Table 88. Global Human Immunoglobulin for Intravenous Injection Revenue by Region (2021-2026) & (US$ Million) Table 89. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Region (2021-2026) Table 90. Global Human Immunoglobulin for Intravenous Injection Revenue by Region (2027-2032) & (US$ Million) Table 91. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Region (2027-2032) Table 92. North America Human Immunoglobulin for Intravenous Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. North America Human Immunoglobulin for Intravenous Injection Sales by Country (2021-2026) & (K Units) Table 94. North America Human Immunoglobulin for Intravenous Injection Sales by Country (2027-2032) & (K Units) Table 95. North America Human Immunoglobulin for Intravenous Injection Revenue by Country (2021-2026) & (US$ Million) Table 96. North America Human Immunoglobulin for Intravenous Injection Revenue by Country (2027-2032) & (US$ Million) Table 97. Europe Human Immunoglobulin for Intravenous Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Europe Human Immunoglobulin for Intravenous Injection Sales by Country (2021-2026) & (K Units) Table 99. Europe Human Immunoglobulin for Intravenous Injection Sales by Country (2027-2032) & (K Units) Table 100. Europe Human Immunoglobulin for Intravenous Injection Revenue by Country (2021-2026) & (US$ Million) Table 101. Europe Human Immunoglobulin for Intravenous Injection Revenue by Country (2027-2032) & (US$ Million) Table 102. Asia Pacific Human Immunoglobulin for Intravenous Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Asia Pacific Human Immunoglobulin for Intravenous Injection Sales by Country (2021-2026) & (K Units) Table 104. Asia Pacific Human Immunoglobulin for Intravenous Injection Sales by Country (2027-2032) & (K Units) Table 105. Asia Pacific Human Immunoglobulin for Intravenous Injection Revenue by Country (2021-2026) & (US$ Million) Table 106. Asia Pacific Human Immunoglobulin for Intravenous Injection Revenue by Country (2027-2032) & (US$ Million) Table 107. South America Human Immunoglobulin for Intravenous Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. South America Human Immunoglobulin for Intravenous Injection Sales by Country (2021-2026) & (K Units) Table 109. South America Human Immunoglobulin for Intravenous Injection Sales by Country (2027-2032) & (K Units) Table 110. South America Human Immunoglobulin for Intravenous Injection Revenue by Country (2021-2026) & (US$ Million) Table 111. South America Human Immunoglobulin for Intravenous Injection Revenue by Country (2027-2032) & (US$ Million) Table 112. Middle East and Africa Human Immunoglobulin for Intravenous Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Middle East and Africa Human Immunoglobulin for Intravenous Injection Sales by Country (2021-2026) & (K Units) Table 114. Middle East and Africa Human Immunoglobulin for Intravenous Injection Sales by Country (2027-2032) & (K Units) Table 115. Middle East and Africa Human Immunoglobulin for Intravenous Injection Revenue by Country (2021-2026) & (US$ Million) Table 116. Middle East and Africa Human Immunoglobulin for Intravenous Injection Revenue by Country (2027-2032) & (US$ Million) Table 117. Global Human Immunoglobulin for Intravenous Injection Sales by Type (2021-2026) & (K Units) Table 118. Global Human Immunoglobulin for Intravenous Injection Sales by Type (2027-2032) & (K Units) Table 119. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Type (2021-2026) Table 120. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Type (2027-2032) Table 121. Global Human Immunoglobulin for Intravenous Injection Revenue by Type (2021-2026) & (US$ Million) Table 122. Global Human Immunoglobulin for Intravenous Injection Revenue by Type (2027-2032) & (US$ Million) Table 123. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Type (2021-2026) Table 124. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Type (2027-2032) Table 125. Global Human Immunoglobulin for Intravenous Injection Price by Type (2021-2026) & (US$/Unit) Table 126. Global Human Immunoglobulin for Intravenous Injection Price by Type (2027-2032) & (US$/Unit) Table 127. Global Human Immunoglobulin for Intravenous Injection Sales by Application (2021-2026) & (K Units) Table 128. Global Human Immunoglobulin for Intravenous Injection Sales by Application (2027-2032) & (K Units) Table 129. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Application (2021-2026) Table 130. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Application (2027-2032) Table 131. Global Human Immunoglobulin for Intravenous Injection Revenue by Application (2021-2026) & (US$ Million) Table 132. Global Human Immunoglobulin for Intravenous Injection Revenue by Application (2027-2032) & (US$ Million) Table 133. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Application (2021-2026) Table 134. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Application (2027-2032) Table 135. Global Human Immunoglobulin for Intravenous Injection Price by Application (2021-2026) & (US$/Unit) Table 136. Global Human Immunoglobulin for Intravenous Injection Price by Application (2027-2032) & (US$/Unit) Table 137. Key Raw Materials Table 138. Raw Materials Key Suppliers Table 139. Human Immunoglobulin for Intravenous Injection Distributors List Table 140. Human Immunoglobulin for Intravenous Injection Customers List Table 141. Human Immunoglobulin for Intravenous Injection Industry Trends Table 142. Human Immunoglobulin for Intravenous Injection Industry Drivers Table 143. Human Immunoglobulin for Intravenous Injection Industry Restraints Table 144. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Human Immunoglobulin for Intravenous Injection Product Image Figure 5. Global Human Immunoglobulin for Intravenous Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Human Immunoglobulin for Intravenous Injection Market Size (2021-2032) & (US$ Million) Figure 7. Global Human Immunoglobulin for Intravenous Injection Sales (2021-2032) & (K Units) Figure 8. Global Human Immunoglobulin for Intravenous Injection Average Price (US$/Unit) & (2021-2032) Figure 9. Children Product Image Figure 10. Adult Product Image Figure 11. Treatment Product Image Figure 12. Diagnosis Product Image Figure 13. Disease Prevention Product Image Figure 14. Other Product Image Figure 15. Global Human Immunoglobulin for Intravenous Injection Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Human Immunoglobulin for Intravenous Injection, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Human Immunoglobulin for Intravenous Injection Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Human Immunoglobulin for Intravenous Injection Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Human Immunoglobulin for Intravenous Injection Sales by Region in 2025 Figure 21. Global Human Immunoglobulin for Intravenous Injection Revenue by Region in 2025 Figure 22. North America Human Immunoglobulin for Intravenous Injection Market Size by Country in 2025 Figure 23. North America Human Immunoglobulin for Intravenous Injection Sales Market Share by Country (2021-2032) Figure 24. North America Human Immunoglobulin for Intravenous Injection Revenue Market Share by Country (2021-2032) Figure 25. United States Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Human Immunoglobulin for Intravenous Injection Market Size by Country in 2025 Figure 28. Europe Human Immunoglobulin for Intravenous Injection Sales Market Share by Country (2021-2032) Figure 29. Europe Human Immunoglobulin for Intravenous Injection Revenue Market Share by Country (2021-2032) Figure 30. Germany Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Netherlands Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Asia Pacific Human Immunoglobulin for Intravenous Injection Market Size by Country in 2025 Figure 36. Asia Pacific Human Immunoglobulin for Intravenous Injection Sales Market Share by Country (2021-2032) Figure 37. Asia Pacific Human Immunoglobulin for Intravenous Injection Revenue Market Share by Country (2021-2032) Figure 38. China Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Japan Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. South Korea Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. India Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Australia Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. China Taiwan Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Southeast Asia Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Southeast Asia Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South America Human Immunoglobulin for Intravenous Injection Market Size by Country in 2025 Figure 47. South America Human Immunoglobulin for Intravenous Injection Sales Market Share by Country (2021-2032) Figure 48. South America Human Immunoglobulin for Intravenous Injection Revenue Market Share by Country (2021-2032) Figure 49. Mexico Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Brazil Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Argentina Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Middle East and Africa Human Immunoglobulin for Intravenous Injection Market Size by Country in 2025 Figure 53. Middle East and Africa Human Immunoglobulin for Intravenous Injection Sales Market Share by Country (2021-2032) Figure 54. Middle East and Africa Human Immunoglobulin for Intravenous Injection Revenue Market Share by Country (2021-2032) Figure 55. Turkey Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Saudi Arabia Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. UAE Human Immunoglobulin for Intravenous Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Type (2021-2032) Figure 59. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Type (2021-2032) Figure 60. Global Human Immunoglobulin for Intravenous Injection Price (US$/Unit) by Type (2021-2032) Figure 61. Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Application (2021-2032) Figure 62. Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Application (2021-2032) Figure 63. Global Human Immunoglobulin for Intravenous Injection Price (US$/Unit) by Application (2021-2032) Figure 64. Human Immunoglobulin for Intravenous Injection Value Chain Figure 65. Human Immunoglobulin for Intravenous Injection Production Mode & Process Figure 66. Direct Comparison with Distribution Share Figure 67. Distributors Profiles Figure 68. Human Immunoglobulin for Intravenous Injection Industry Opportunities and Challenges

Scope & coverage.

Types
  • Children
  • Adult
Applications
  • Treatment
  • Diagnosis
  • Disease Prevention
  • Other
Companies covered
  • Zhenghua Shenghua
  • Zhongyuan Ruide
  • Weiguang Biological
  • Tiantan Biological
  • Taibang Biological
  • Yuanda shuyang
  • Shanghai Laishi
  • Kangbao Biological
  • Nanyue Biological
  • Lvshizi
  • Hualan Biological
  • Paisi feike
  • Boya Biological

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Human Immunoglobulin for Intravenous Injection Market Size (2021-2032)
  4. 2.2.2 Global Human Immunoglobulin for Intravenous Injection Sales (2021-2032)
  5. 2.2.3 Global Human Immunoglobulin for Intravenous Injection Market Average Price (2021-2032)
  6. 2.3 Human Immunoglobulin for Intravenous Injection by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Children
  9. 2.3.3 Adult
  10. 2.4 Human Immunoglobulin for Intravenous Injection by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Treatment
  13. 2.4.3 Diagnosis
  14. 2.4.4 Disease Prevention
  15. 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Human Immunoglobulin for Intravenous Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Human Immunoglobulin for Intravenous Injection Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Human Immunoglobulin for Intravenous Injection Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Human Immunoglobulin for Intravenous Injection Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Human Immunoglobulin for Intravenous Injection Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Human Immunoglobulin for Intravenous Injection, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Human Immunoglobulin for Intravenous Injection, Product Type & Application
  8. 3.8 Global Manufacturers of Human Immunoglobulin for Intravenous Injection, Established Date
  9. 3.9 Global Human Immunoglobulin for Intravenous Injection Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Zhenghua Shenghua
  2. 4.1.1 Zhenghua Shenghua Company Information
  3. 4.1.2 Zhenghua Shenghua Business Overview
  4. 4.1.3 Zhenghua Shenghua Human Immunoglobulin for Intravenous Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Zhenghua Shenghua Human Immunoglobulin for Intravenous Injection Product Portfolio
  6. 4.1.5 Zhenghua Shenghua Recent Developments
  7. 4.2 Zhongyuan Ruide
  8. 4.2.1 Zhongyuan Ruide Company Information
  9. 4.2.2 Zhongyuan Ruide Business Overview
  10. 4.2.3 Zhongyuan Ruide Human Immunoglobulin for Intravenous Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Zhongyuan Ruide Human Immunoglobulin for Intravenous Injection Product Portfolio
  12. 4.2.5 Zhongyuan Ruide Recent Developments
  13. 4.3 Weiguang Biological
  14. 4.3.1 Weiguang Biological Company Information
  15. 4.3.2 Weiguang Biological Business Overview
  16. 4.3.3 Weiguang Biological Human Immunoglobulin for Intravenous Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Weiguang Biological Human Immunoglobulin for Intravenous Injection Product Portfolio
  18. 4.3.5 Weiguang Biological Recent Developments
  19. 4.4 Tiantan Biological
  20. 4.4.1 Tiantan Biological Company Information
  21. 4.4.2 Tiantan Biological Business Overview
  22. 4.4.3 Tiantan Biological Human Immunoglobulin for Intravenous Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Tiantan Biological Human Immunoglobulin for Intravenous Injection Product Portfolio
  24. 4.4.5 Tiantan Biological Recent Developments
  25. 4.5 Taibang Biological
  26. 4.5.1 Taibang Biological Company Information
  27. 4.5.2 Taibang Biological Business Overview
  28. 4.5.3 Taibang Biological Human Immunoglobulin for Intravenous Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Taibang Biological Human Immunoglobulin for Intravenous Injection Product Portfolio
  30. 4.5.5 Taibang Biological Recent Developments
  31. 4.6 Yuanda shuyang
  32. 4.6.1 Yuanda shuyang Company Information
  33. 4.6.2 Yuanda shuyang Business Overview
  34. 4.6.3 Yuanda shuyang Human Immunoglobulin for Intravenous Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Yuanda shuyang Human Immunoglobulin for Intravenous Injection Product Portfolio
  36. 4.6.5 Yuanda shuyang Recent Developments
  37. 4.7 Shanghai Laishi
  38. 4.7.1 Shanghai Laishi Company Information
  39. 4.7.2 Shanghai Laishi Business Overview
  40. 4.7.3 Shanghai Laishi Human Immunoglobulin for Intravenous Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Shanghai Laishi Human Immunoglobulin for Intravenous Injection Product Portfolio
  42. 4.7.5 Shanghai Laishi Recent Developments
  43. 4.8 Kangbao Biological
  44. 4.8.1 Kangbao Biological Company Information
  45. 4.8.2 Kangbao Biological Business Overview
  46. 4.8.3 Kangbao Biological Human Immunoglobulin for Intravenous Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Kangbao Biological Human Immunoglobulin for Intravenous Injection Product Portfolio
  48. 4.8.5 Kangbao Biological Recent Developments
  49. 4.9 Nanyue Biological
  50. 4.9.1 Nanyue Biological Company Information
  51. 4.9.2 Nanyue Biological Business Overview
  52. 4.9.3 Nanyue Biological Human Immunoglobulin for Intravenous Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Nanyue Biological Human Immunoglobulin for Intravenous Injection Product Portfolio
  54. 4.9.5 Nanyue Biological Recent Developments
  55. 4.10 Lvshizi
  56. 4.10.1 Lvshizi Company Information
  57. 4.10.2 Lvshizi Business Overview
  58. 4.10.3 Lvshizi Human Immunoglobulin for Intravenous Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Lvshizi Human Immunoglobulin for Intravenous Injection Product Portfolio
  60. 4.10.5 Lvshizi Recent Developments
  61. 4.11 Hualan Biological
  62. 4.11.1 Hualan Biological Company Information
  63. 4.11.2 Hualan Biological Business Overview
  64. 4.11.3 Hualan Biological Human Immunoglobulin for Intravenous Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Hualan Biological Human Immunoglobulin for Intravenous Injection Product Portfolio
  66. 4.11.5 Hualan Biological Recent Developments
  67. 4.12 Paisi feike
  68. 4.12.1 Paisi feike Company Information
  69. 4.12.2 Paisi feike Business Overview
  70. 4.12.3 Paisi feike Human Immunoglobulin for Intravenous Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Paisi feike Human Immunoglobulin for Intravenous Injection Product Portfolio
  72. 4.12.5 Paisi feike Recent Developments
  73. 4.13 Boya Biological
  74. 4.13.1 Boya Biological Company Information
  75. 4.13.2 Boya Biological Business Overview
  76. 4.13.3 Boya Biological Human Immunoglobulin for Intravenous Injection Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Boya Biological Human Immunoglobulin for Intravenous Injection Product Portfolio
  78. 4.13.5 Boya Biological Recent Developments
5 Global Human Immunoglobulin for Intravenous Injection Market Scenario by Region
  1. 5.1 Global Human Immunoglobulin for Intravenous Injection Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Human Immunoglobulin for Intravenous Injection Sales by Region: 2021-2032
  3. 5.2.1 Global Human Immunoglobulin for Intravenous Injection Sales by Region: 2021-2026
  4. 5.2.2 Global Human Immunoglobulin for Intravenous Injection Sales by Region: 2027-2032
  5. 5.3 Global Human Immunoglobulin for Intravenous Injection Revenue by Region: 2021-2032
  6. 5.3.1 Global Human Immunoglobulin for Intravenous Injection Revenue by Region: 2021-2026
  7. 5.3.2 Global Human Immunoglobulin for Intravenous Injection Revenue by Region: 2027-2032
  8. 5.4 North America Human Immunoglobulin for Intravenous Injection Market Facts & Figures by Country
  9. 5.4.1 North America Human Immunoglobulin for Intravenous Injection Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Human Immunoglobulin for Intravenous Injection Sales by Country (2021-2032)
  11. 5.4.3 North America Human Immunoglobulin for Intravenous Injection Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Human Immunoglobulin for Intravenous Injection Market Facts & Figures by Country
  15. 5.5.1 Europe Human Immunoglobulin for Intravenous Injection Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Human Immunoglobulin for Intravenous Injection Sales by Country (2021-2032)
  17. 5.5.3 Europe Human Immunoglobulin for Intravenous Injection Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Human Immunoglobulin for Intravenous Injection Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Human Immunoglobulin for Intravenous Injection Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Human Immunoglobulin for Intravenous Injection Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Human Immunoglobulin for Intravenous Injection Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Human Immunoglobulin for Intravenous Injection Market Facts & Figures by Country
  35. 5.7.1 South America Human Immunoglobulin for Intravenous Injection Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Human Immunoglobulin for Intravenous Injection Sales by Country (2021-2032)
  37. 5.7.3 South America Human Immunoglobulin for Intravenous Injection Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Human Immunoglobulin for Intravenous Injection Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Human Immunoglobulin for Intravenous Injection Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Human Immunoglobulin for Intravenous Injection Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Human Immunoglobulin for Intravenous Injection Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Human Immunoglobulin for Intravenous Injection Sales by Type (2021-2032)
  2. 6.1.1 Global Human Immunoglobulin for Intravenous Injection Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Type (2021-2032)
  4. 6.2 Global Human Immunoglobulin for Intravenous Injection Revenue by Type (2021-2032)
  5. 6.2.1 Global Human Immunoglobulin for Intravenous Injection Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Human Immunoglobulin for Intravenous Injection Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Human Immunoglobulin for Intravenous Injection Sales by Application (2021-2032)
  2. 7.1.1 Global Human Immunoglobulin for Intravenous Injection Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Human Immunoglobulin for Intravenous Injection Sales Market Share by Application (2021-2032)
  4. 7.2 Global Human Immunoglobulin for Intravenous Injection Revenue by Application (2021-2032)
  5. 7.2.1 Global Human Immunoglobulin for Intravenous Injection Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Human Immunoglobulin for Intravenous Injection Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Human Immunoglobulin for Intravenous Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Human Immunoglobulin for Intravenous Injection Value Chain Analysis
  2. 8.1.1 Human Immunoglobulin for Intravenous Injection Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Human Immunoglobulin for Intravenous Injection Production Mode & Process
  5. 8.2 Human Immunoglobulin for Intravenous Injection Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Human Immunoglobulin for Intravenous Injection Distributors
  8. 8.2.3 Human Immunoglobulin for Intravenous Injection Customers
9 Global Human Immunoglobulin for Intravenous Injection Analyzing Market Dynamics
  1. 9.1 Human Immunoglobulin for Intravenous Injection Industry Trends
  2. 9.2 Human Immunoglobulin for Intravenous Injection Industry Drivers
  3. 9.3 Human Immunoglobulin for Intravenous Injection Industry Opportunities and Challenges
  4. 9.4 Human Immunoglobulin for Intravenous Injection Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst